Why do healthy volunteers participate in clinical trials?
British Journal of Clinical Pharmacology · 2026
DOI: 10.1002/bcp.70499 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Thijs van Iersel und 5 weiteren Autor:innen. Beteiligte Einrichtung: ICON, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Motivation, Healthy Volunteers, Clinical Trials, Phase I as Topic, Clinical Trials as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
To better understand the motivations and needs of healthy volunteers in clinical trials.
Methods
The European Federation for Exploratory Medicines Development (EUFEMED) devised a Survey of 58 questions on motivations of volunteers to participate, as well as on needs at the level of convenience, risk/benefit, social interaction, partnership and altruism. The Survey was shared with European Clinical Research Units (CRUs) who agreed to conduct the Survey in volunteers taking part in their phase 1 trials.
Results
The Survey generated responses from 4349 healthy volunteers. In 54% (95% CI: 52,55) of cases contributing to new treatments was the primary motivation to participate, vs . monetary compensation in 41% (95% CI: 39,42) of responders. Volunteer requirements during overnight stays defined as important were well‐functioning showers (89%, 95% CI: 87,90), ability to spend some time outside (78%, 95% CI: 76,80), the meal quality (76%, 95% CI 73,78), access to high‐speed internet (73%, 95% CI: 71,75), a place to read/work alone (69%, 95% CI: 66,71) and a good night rest (69%, 95% CI: 67,71). The opportunity to socialize with staff was important for 85% (95% CI: 83,87), a unit with a cozy interior for 70% (95% CI 67,72) and socializing with other participants for 63% (95% CI 61,66) of responders.
Conclusion
Healthy volunteers in clinical trials have specific needs during their stay in the Clinical Research Unit. Volunteer recruitment, compliance and retainment, as well as an ethical and a subject‐centric approach to trial design and conduct can benefit from understanding these needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ICON, Groningen, the Netherlands.
- SGS, Clinical Pharmacology Unit, Antwerpen, Belgium.
- Niche Science & Technology Ltd, London, UK.
- Eurofins Optimed, Grenoble, France.
- Miltenyi, Leiden, the Netherlands.
- Pharmaplex - President, EUFEMED, Wezembeek-Oppem, Belgium.
ORCID-Profile: Thijs van Iersel, Jelle Klein, Timothy C Hardman, Yves Donazzolo, Ingrid Klingmann
Zitieren
APA
van Iersel, T., Klein, J., Hardman, T. C., Donazzolo, Y., de Vries, D., & Klingmann, I. (2026). Why do healthy volunteers participate in clinical trials?. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70499
Vancouver
van Iersel T, Klein J, Hardman TC, Donazzolo Y, de Vries D, Klingmann I. Why do healthy volunteers participate in clinical trials?. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70499
BibTeX
@article{vanIersel2026,
author = {van Iersel, Thijs and Klein, Jelle and Hardman, Timothy C and Donazzolo, Yves and de Vries, Dick and Klingmann, Ingrid},
title = {Why do healthy volunteers participate in clinical trials?},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70499}
}
EUVIMED